Stay updated on Once vs Twice Weekly Carfilzomib in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Once vs Twice Weekly Carfilzomib in Multiple Myeloma Clinical Trial page.

Latest updates to the Once vs Twice Weekly Carfilzomib in Multiple Myeloma Clinical Trial page
- Check3 days agoChange DetectedThe page now indicates that recruitment is closed. New help/navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and the text header formatting has been standardized (Intervention/Treatment), along with a site version update (Revision: v3.6.0).SummaryDifference0.2%

- Check10 days agoChange DetectedRevision tag on the page changed from v3.5.4 to v3.5.5, indicating a behind-the-scenes deployment or update to the site's underlying version.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe page revision metadata was updated to v3.5.4, replacing the prior v3.5.3. This signals a minor release of the page template/document without changes to visible content.SummaryDifference0.0%

- Check53 days agoChange DetectedThis reflects a minor ClinicalTrials.gov site software/version update shown in the page footer, with the study content remaining the same.SummaryDifference0.0%

- Check61 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check90 days agoChange DetectedThe site now displays revision v3.5.0; revision v3.4.3 has been removed.SummaryDifference0.0%

Stay in the know with updates to Once vs Twice Weekly Carfilzomib in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Once vs Twice Weekly Carfilzomib in Multiple Myeloma Clinical Trial page.